---
figid: PMC8415231__fphar-12-719880-g002
figtitle: Targeting the Wnt/Beta-Catenin Signaling Pathway as a Potential Therapeutic
  Strategy in Renal Tubulointerstitial Fibrosis
organisms:
- Lareunionomyces loeiensis
- Agaricus bisporus
- Salvia miltiorrhiza
- Tripterygium wilfordii
- Wolfiporia cocos
- Tropicoporus linteus
- Alisma plantago-aquatica subsp. orientale
- Polyporus umbellatus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Caenorhabditis elegans
pmcid: PMC8415231
filename: fphar-12-719880-g002.jpg
figlink: /pmc/articles/PMC8415231/figure/F2/
number: F2
caption: Potential therapeutic targets in the Wnt/β-catenin signaling. Numerous small
  molecules inhibit Wnt/β-catenin signaling at different steps of the pathway. Porcupine
  inhibitors prevent Wnt ligands secretion. Receptor or co-receptor inhibitors prevent
  the receptor actions of Wnt ligands. Inhibitors of GSK3β, axin, DVL, and CK1 interfere
  with Wnt/β-catenin downstream signaling. Inhibitors of TCF/LEF suppress Wnt/β-catenin-dependent
  gene transcription. Several natural products alleviate renal fibrosis by regulating
  the Wnt/β-catenin signaling pathway.
papertitle: Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic
  Strategy in Renal Tubulointerstitial Fibrosis.
reftext: Shan-Shan Li, et al. Front Pharmacol. 2021;12:719880.
year: '2021'
doi: 10.3389/fphar.2021.719880
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: Wnt/β-catenin | chronic kidney disease | renal fibrosis | traditional Chinese
  medicine | natural product
automl_pathway: 0.9509705
figid_alias: PMC8415231__F2
figtype: Figure
redirect_from: /figures/PMC8415231__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8415231__fphar-12-719880-g002.html
  '@type': Dataset
  description: Potential therapeutic targets in the Wnt/β-catenin signaling. Numerous
    small molecules inhibit Wnt/β-catenin signaling at different steps of the pathway.
    Porcupine inhibitors prevent Wnt ligands secretion. Receptor or co-receptor inhibitors
    prevent the receptor actions of Wnt ligands. Inhibitors of GSK3β, axin, DVL, and
    CK1 interfere with Wnt/β-catenin downstream signaling. Inhibitors of TCF/LEF suppress
    Wnt/β-catenin-dependent gene transcription. Several natural products alleviate
    renal fibrosis by regulating the Wnt/β-catenin signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MAF
  - MAFA
  - MAFB
  - MAFF
  - MAFG
  - MAFK
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - CTNNB1
  - MGME1
  - SFRP1
  - WIF1
  - APC
  - PROC
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - HNF4A
  - DKK1
  - GSK3A
  - GSK3B
  - TCF19
  - SPARCL1
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - Maf
  - Crebbp
  - Pag1
  - Cytip
  - Ctnnb1
  - Sfrp1
  - Wif1
  - Apc
  - Dvl1
  - Dkk1
  - Gsk3b
  - Alcam
  - Sparcl1
  - Prdm4
  - Scq1
  - Axin1
  - Gm12892
  - Wnt2
  - Mmd
  - Csnk1a1
  - lpr-5
  - lpr-6
  - sfrp-1
  - gsk-3
---
